- The World Health Organization established an arm for the trial of two possible COVID-19 treatments
- However, it declared on Saturday that the trial for hydroxychloroquine and lopinavir/ritonavir needs to be stopped
- Studies showed that the said treatments produced “little or no reduction in the mortality” of infected patients
- As of this writing, the effective drug against the novel coronavirus has yet to be discovered
The World Health Organization (WHO) disclosed on July 4 that it will already put an end to the trial of two possible treatments for the novel coronavirus disease.
KAMI learned that the said organization has accepted the recommendation of the International Steering Committee regarding hydroxychloroquine and lopinavir/ritonavir.
The official website of WHO reported that the said combined treatment produces “little or no reduction in the mortality” of those who tested positive for the virus.
CNCB, meanwhile, stated in a recent report that the decision to halt the said trial is only applicable to those who are admitted to hospitals.
“WHO today accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms,” the WHO quipped through an official statement.
As of this writing, a vaccine or effective drug against COVID-19 has yet to be discovered. Many medical firms have joined the global race of finding the best solution versus the virus.
The novel coronavirus continues to become one of the most fatal health crises not just in the Philippines but in the whole world.
The WHO stated that out of 100 vaccine candidates, one is already at the advanced stage of development.
An Italian doctor also recently claimed that the virus is already becoming less dangerous and it may disappear without the need for a vaccine.
Please like and share our Facebook posts to support KAMI team! Don’t hesitate to comment and share your opinion about our stories either. We love reading about your thoughts!